The trial aims to evaluate the possibility of decreasing chemotherapy exposure for subjects who show an early response to treatment ... will switch to nivolumab monotherapy for two cycles after only ...

For nearly 20 years, mesothelioma treatment options were limited to a single regimen: pemetrexed with a platinum agent. Now, ...

CEL-SCI (CVM) announced that a third-party study published on March 6 in JAMA Oncology provided data that support Multikine’s use as a ...

Currently, the standard treatment for newly diagnosed advanced ... who will receive two cycles of nivolumab + AVD therapy (doxorubicin, vinblastine, and dacarbazine). After an interim assessment ...